26 Stocks Moving In Friday's Pre-Market Session

Gainers

• Legacy Reserves Inc LGCY shares rose 96.4% to $0.10 in pre-market trading, reversing from recent weakness. Shares fell earlier this week after the company filed for Chapter 11 bankruptcy protection.
• ContraVir Pharmaceuticals, Inc. CTRV rose 61.5% to $6.93 in pre-market trading after the FDA responded to the company’s IND package and concurred with the company’s proposed plan for further preclinical studies to support the development of CRV431 in NASH.
• Lifeway Foods, Inc. . LWAY shares rose 9.1% to $3.98 in pre-market trading. Lifeway Foods shares jumped over 26% Thursday after the company announced it will enter the CBD space with CBD drinkables once it is legalized at federal level by FDA.
• Arbutus Biopharma Corporation ABUS rose 8.5% to $2.56 in pre-market trading after surging 37.21% on Thursday.
• Achieve Life Sciences, Inc. ACHV rose 5.4% to $2.54 in pre-market trading after the company disclosed that Phase 2b ORCA-1 trial data has been accepted for oral presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) Annual Conference.
• Mustang Bio, Inc. MBIO rose 5.3% to $3.55 in pre-market trading after falling 6.91% on Thursday.
• IAMGOLD Corporation IAG rose 4.6% to $3.39 in pre-market trading after climbing 7.64% on Thursday.
• The Meet Group, Inc.. MEET rose 4.6% to $3.65 in pre-market trading. Oppenheimer initiated coverage on The Meet Group with an Outperform rating.
• Verastem Inc VSTM rose 4.4% to $1.66 in pre-market trading after the company presented COPIKTRA data showing response rates of 44-57%, including complete response rates of 15-22% in patients with relapsed or refractory peripheral T-cell lymphoma.
• Rapid7, Inc. RPD rose 4.4% to $59.84 in pre-market trading after gaining 5.06% on Thursday.
• CarMax, Inc KMX rose 3.9% to $86.23 in pre-market trading after the company reported better-than-expected Q1 EPS and sales.
• Nabors Industries Ltd. NBR rose 3% to $2.77 in pre-market trading after gaining 8.91% on Thursday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Get Started

Earn 7.2% — No Matter What the Fed Does

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds.

Get Started

Check out these big penny stock gainers and losers

Losers

• AnaptysBio, Inc. ANAB fell 15.1% to $56.90 in pre-market trading after Credit Suisse downgraded the stock from Outperform to Neutral.
• Hertz Global Holdings, Inc. HTZ shares fell 11.6% to $16.50 in pre-market trading.
• Akerna Corp. KERN fell 7% to $34.00 in pre-market trading after dropping 26.61% on Thursday.
• Melinta Therapeutics, Inc. MLNT fell 6.6% to $4.93 in pre-market trading after dropping 17.63% on Thursday.
• Brookfield Business Partners L.P. BBU shares fell 6.2% to $38.67 in pre-market trading after reporting a $795 million equity offering.
• 500.com Limited WBAI fell 5.6% to $9.33 in pre-market trading after rising 6.93% on Thursday.
• Beyond Meat, Inc. BYND fell 5.6% to $156.00 in pre-market trading.
• Exelixis, Inc. EXEL fell 5.4% to $20.00 in pre-market trading.
• Canopy Growth Corp CGC fell 4.8% to $41.60 in pre-market trading after the company posted its financial results for the fiscal fourth quarter ended March 31, which included annual net revenue growth of 191%.
• Carnival Corporation CCL fell 4.5% to $46.61 in pre-market trading after Barclays downgraded the company's stock from Overweight to Equal-Weight and lowered the price target from $69 to $55. Nomura also downgraded the stock from Buy to Neutral and lowered the price target from $60 to $52. The company on Thursday cut FY19 guidance.
• BioTelemetry, Inc. BEAT fell 4.2% to $49.00 in pre-market trading.
• MoneyGram International, Inc. MGI fell 4.1% to $2.56 in pre-market trading after declining 8.87% on Thursday.
• Edesa Biotech, Inc. EDSA fell 4% to $7.11 in pre-market trading after jumping 74.94% on Thursday.
• Alexandria Real Estate Equities Inc ARE fell 2.3% to $146.50 in pre-market trading. Alexandria Real Estate Equities priced upsized public offering of 3.85 million shares of common stock at $145 per share.